HUBUNGAN KONSUMSI OBAT DIABETES DENGAN PENYAKIT JANTUNG KORONER
DOI:
https://doi.org/10.31004/jkt.v4i3.17584Keywords:
IFLS, konsumsi obat diabetes, penyakit jantung koronerAbstract
Diabetes melitus merupakan salah satu penyakit yang dapat menimbulkan komplikasi yang berakibat munculnya penyakit lainnya. Penyakit kardiovaskuler merupakan penyakit dengan kejadian tertinggi yang menjadi komplikasi pada penderita diabetes melitus dan penyakit jantung koroner merupakan yang paling tinggi . Beberapa jenis obat diabetes memiliki efek kardioprotektif yang dapat mencegah timbulnya penyakit jantung koroner pada diabetesi. Hubungan antara konsumsi obat diabetes melitus masih belum banyak dijelaskan dalam beberapa penelitian sebelumnya. Penelitian ini bertujuan untuk mengetahui hubungan konsumsi obat diabetes dengan penyakit jantung koroner. Penelitian analitik kuantitatif dengan desain cross-sectional menggunakan data Indonesian Family Life Survey dengan jumlah sampel sebanyal 6.676 responden berusia >19 tahun yang diambil dari keseluruhan responden Indonesian Family Life Suervey sebagai populasi penelitian. Variabel independen dari penelitian ini adalah konsumsi obat diabetes, sedangkan variabel dependen dalam penelitian ini adalah penyakit jantung koroner. Hubungan antara variabel dependen dan independen diketahui dengan analisis statistik uji Chi-Square menggunakan software SPSS. Konsumsi obat diabetes memiliki hubungan bermakna dengan penyakit jantung koroner (p <0,001, OR = 2,37) yang menunjukkan bahwa penderita diabetes melitus yang mengonsumsi obat diabetes akan mengalami penyakit jantung koroner 2,37 kali dari penderita diabetes melitus yang tidak mengonsumsi obat diabetes Konsumsi obat diabetes berhubungan dengan penyakit jantung koroner.References
Baniu, A. S., Sauriasari, R., Riyadina, W., & Soewondo, P. (2022). Treatment Adherence and Incidence of Coronary Heart Diseasein Type 2 Diabetes Mellitus Patients. Kesmas, 17(2), 98–104. https://doi.org/10.21109/kesmas.v17i2.5453
Chen, J., Yin, D., & Dou, K. (2023). Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions. Cardiovascular Diabetology, 22(1), 1–16. https://doi.org/10.1186/s12933-023-01875-8
Chiha, M., Njeim, M., & Chedrawy, E. G. (2012). Diabetes and coronary heart disease: A risk factor for the global epidemic. International Journal of Hypertension, 2012. https://doi.org/10.1155/2012/697240
Gyldenkerne, C., Olesen, K. K. W., Madsen, M., Thim, T., Jensen, L. O., Raungaard, B., Sørensen, H. T., Bøtker, H. E., & Maeng, M. (2019). Association between anti-diabetes treatments and cardiovascular risk in diabetes patients with and without coronary artery disease. Diabetes and Vascular Disease Research, 16(4), 351–359. https://doi.org/10.1177/1479164119836227
Huxley, R. R., Filion, K. B., Konety, S., & Alvaro Alonso. (2011). Meta-Analysis of Cohort and Case Control Studies of Type-2 Diabetes Melitus and Risk of Atrial Fibrilation. American Journal of Cardiology, 1(1), 56–62. https://doi.org/10.1016/j.amjcard.2011.03.004.Meta-analysis
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., & Sperling, L. S. (2022). Comprehensive Management of Cardiovascular Risk Factors for Adults with Type 2 Diabetes: A Scientific Statement from the American Heart Association. In Circulation (Vol. 145, Issue 9). https://doi.org/10.1161/CIR.0000000000001040
Lin, X., Xu, Y., Pan, X., Xu, J., Ding, Y., Sun, X., Song, X., Ren, Y., & Shan, P. F. (2020). Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific Reports, 10(1), 1–11. https://doi.org/10.1038/s41598-020-71908-9
Poulsen, M. K., Henriksen, J. E., Dahl, J., Johansen, A., Gerke, O., Vach, W., Haghfelt, T., Høilund-Carlsen, P. F., Beck-Nielsen, H., & Møller, J. E. (2010). Left ventricular diastolic function in type 2 diabetes mellitus prevalence and association with myocardial and vascular disease. Circulation: Cardiovascular Imaging, 3(1), 24–31. https://doi.org/10.1161/CIRCIMAGING.109.855510
Strauss, J., Witoelar, F., & Sikoki, B. (2016). The Fifth Wave of the Indonesia Family Life Survey: Overview and Field Report: Volume 1. The Fifth Wave of the Indonesia Family Life Survey: Overview and Field Report: Volume 1, 1(March). https://doi.org/10.7249/wr1143.1
Tappi, V. E., Nelwan, J. E., & Kandou, G. D. (2018). Hubungan Antara Aktivitas Fisik Dan Riwayat Keluarga Dengan Kejadian Penyakit Jantung Koroner Di Badan Layanan Umum Rumah Sakit Umum Pusat Prof. Dr. R. D. Kandou Manado. Kesmas, 7(4), 1–9. http://ejournalhealth.com/index.php/kesmas/article/view/895
Widiarti, W., Sukmajaya, A. C., Nugraha, D., & Alkaff, F. F. (2021). Cardioprotective properties of glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus patients: A systematic review. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 15(3), 837–843. https://doi.org/10.1016/j.dsx.2021.04.005
Kemenkes RI. 2018. Laporan Nasional RISKESDAS 2018. Jakarta : LPB Penelitian dan Pengembangan Kesehatan. Tersedia di: http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf [20 Juni 2022]
PERKENI. 2021. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. Indonesia ; PB PERKENI. Tersedia di: https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-Website-Pedoman-Pengelolaan-dan-Pencegahan-DMT2-Ebook.pdf [20 Juni 2022]
WHO. 2016. Global Report on Diabetes. Switzerland: WHO Press. Tersedia di: https://www.who.int/publications/i/item/9789241565257 [19 Juni 2022]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anisa Jannatin Naim
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
